Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA–D Melanoma
Authors:
- 3 January 2021
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (8) , 4561-4569
Abstract
Follow-up for patients with resected stage IIIA–D melanoma may include computed tomography (CT) or positron emission tomography (PET)/CT imaging to iKeywords
Funding Information
- Cancer Australia (1129568)
- National Health and Medical Research Council (1135285, 1150989)
- University of Sydney (Robinson Fellowship)
This publication has 22 references indexed in Scilit:
- Why cancer screening has never been shown to “save lives”—and what we can do about itBMJ, 2016
- Is Surveillance Imaging Effective for Detecting Surgically Treatable Recurrences in Patients With Melanoma? A Comparative Analysis of Stage-Specific Surveillance StrategiesAnnals of Surgery, 2014
- Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanomaThe American Journal of Surgery, 2014
- Value of positron emission tomography scan in stage III cutaneous melanoma: A systematic review and meta-analysisSurgical Oncology, 2014
- Radiation-Related Cancer Risk Associated With Surveillance Imaging for Metastasis From Choroidal MelanomaJAMA Ophthalmology, 2013
- The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrenceMelanoma Research, 2011
- Review of Diagnostic Imaging Modalities for the Surveillance of Melanoma PatientsDermatology Research and Practice, 2011
- Contemporary Diagnostic Imaging Modalities for the Staging and Surveillance of Melanoma Patients: a Meta-analysisJNCI: Journal of the National Cancer Institute, 2010
- Site and Timing of First Relapse in Stage III Melanoma Patients: Implications for Follow-Up GuidelinesJournal of Clinical Oncology, 2010
- Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanomaNuclear Medicine Communications, 2007